Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Pharmacology and Therapeutics|January 24, 2006
Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine basesT Ka, T Inokuchi, Z Tsutsumi, et al.
Metabolism: Clinical and Experimental|July 1, 1997
Is the plasma uridine level a marker of the overproduction of uric acid?T Yamamoto, Y Moriwaki, S Takahashi, et al.
Metabolism: Clinical and Experimental|March 21, 1998
Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with goutS Takahashi, T Yamamoto, Y Moriwaki, et al.
Annals of the Rheumatic Diseases|May 22, 2003
Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolismS Takahashi, Y Moriwaki, T Yamamoto, et al.
Metabolism: Clinical and Experimental|October 10, 1997
Close correlation between visceral fat accumulation and uric acid metabolism in healthy menS Takahashi, T Yamamoto, Z Tsutsumi, et al.
Biochimica Et Biophysica Acta|June 3, 1999
Effect of interferon-gamma on purine catabolic and salvage enzyme activities in ratsY Moriwaki, T Yamamoto, J Yamakita, et al.
Metabolism: Clinical and Experimental|April 17, 1999
Effects of fructose and xylitol on the urinary excretion of adenosine, uridine, and purine basesT Yamamoto, Y Moriwaki, S Takahashi, et al.
Metabolism: Clinical and Experimental|April 5, 2001
Increased visceral fat accumulation further aggravates the risks of insulin resistance in goutS Takahashi, Y Moriwaki, Z Tsutsumi, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1996
Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fastingT Yamamoto, Y Moriwaki, S Takahashi, et al.
Pageof 6